Renal Cancer

Glucarpidase (Voraxaze)

This slideshow reviews Glucarpidase (Voraxaze) for the treatment of toxic plasma methotrexate concentrations (>1 μmol/L) in patients with delayed methotrexate clearance due to impaired renal function.

'Index patients' aid mCRPC guideline

‘Index patients’ aid mCRPC guideline

The AUA developed its new clinical guideline on castration-resistant prostate cancer by creating six index patients to represent the most common clinical scenarios encountered when managing the disease.

Next post in In the News